Pretreatment with 9-hydroxyaristoquinolone at 50 μM, which decreased the P-IκBα/IκBα ratio by 90%, suggests an anti-inflammatory effect that could mitigate neuroinflammatory processes associated with pathologies such as Alzheimer’s and Parkinson’s disease. The gene discussed is NFKBIA; the disease is Parkinson disease.